Symptoms of Parkinson’s disease, such as tremors and stiffness, can make daily tasks difficult. A new drug has shown promise in alleviating symptoms. Tavapadon, a drug being tested to treat early ...

Roche RHHBY announced that it will advance pipeline candidate prasinezumab into phase III development for early-stage Parkinson’s disease. Roche has a licensing agreement with Prothena PRTA for ...

(Reuters) -AbbVie's drug met the main goal in a late-stage trial when tested in patients with early Parkinson's disease, the company said on Thursday. Patients showed a statistically significant ...

AC Immune (NASDAQ:ACIU) surged 25% on Thursday after announcing promising interim Phase 2 findings for its experimental ...

A test that can detect Parkinson's disease in the early stages of the illness has moved a step closer. Scientists have developed a way of detecting a molecule linked to the condition in samples of ...

Exercise in general can help patients manage symptoms, but without head-to-head trials, the ‘best’ exercise is the one the patient can do well and will stick with, experts say.

Alabama's voice in the fight against Parkinson's disease is being heard on both national and international stages, thanks to the Parkinson Association of Alabama's (PAA) leadership within the ...

We've already seen a pen that helps people with Parkinson's disease to write clearly, but this one is a little different. By assessing its user's hand movements as they write, it can provide an early ...

FILE PHOTO: Test tubes are seen in front of a displayed Abbvie logo in this illustration (Reuters) -AbbVie's drug met the main goal in a late-stage trial when tested in patients with early Parkinson's ...

Tavapadon, a drug being tested to treat early Parkinson's disease, has shown great promise in a Phase III trial by AbbVie, the pharmaceutical company announced this week. Parkinson’s disease, which is ...